A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
for
Multiple Sclerosis
Location: Montreal
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18 - 65
Code: NCT05704361
Phase1, Recruiting
Featured
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, Newark DE, Fairfax VA, Chapel Hill NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05650632
Phase1, Recruiting
Featured
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
for
Multiple Myeloma
Location: Washington D.C. DC, Winston-Salem NC, Charlotte NC,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07555938
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Boston MA, New Haven CT, New York NY, Chapel Hill NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06953960
Phase1, Phase2, Recruiting
Active & Responsive
Risk Factors in Early Multiple Sclerosis
for
Multiple Sclerosis, Magnetic Resonance Imaging, Biomarkers,
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 30
Code: NCT03586986
Recruiting
Interested in new multiple sclerosis trials?
Get alerts for new trials in your area by subscribing now
Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain